MiSight is a contact lens brand developed by CooperVision. It is the First and only US FDA- approved soft contact lens that is designed to slow progression of myopia in children from ages 8-12.
Clinical studies have found that MiSight can reduce the worsening of myopia by approximately 50%, revolutionising and changing the myopia treatment landscape.